Primary Care Physician Perspectives on Barriers to Statin Treatment

Primary Care Physician Perspectives on Barriers to Statin Treatment Cardiovasc Drugs Ther (2017) 31:303–309 DOI 10.1007/s10557-017-6738-x ORIGINAL ARTICLE Primary Care Physician Perspectives on Barriers to Statin Treatment 1 2 3 3 Rikki M. Tanner & Monika M. Safford & Keri L. Monda & Benjamin Taylor & 4 4 1 5 Ronan O’Beirne & Melanie Morris & Lisandro D. Colantonio & Ricardo Dent & 1 6 Paul Muntner & Robert S. Rosenson Published online: 14 July 2017 Springer Science+Business Media, LLC 2017 Abstract robin fashion. Then, each PCP independently ranked their Purpose Discontinuation of statin therapy represents a major top three responses to each question. For each PCP, the challenge for effective cardiovascular disease prevention. It is most important reason was given a weight of 3 votes, and unclear how often primary care physicians (PCPs) re-initiate the second and third most important reasons were given statins and what barriers they encounter. We aimed to identify weights of 2 and 1, respectively. We categorized the indi- PCP perspectives on factors influencing statin re-initiation. vidual responses into themes and determined the relative Methods We conducted six nominal group discussions with importance of each theme using a Bpercent of available 23 PCPs from the Deep South Continuing Medical Education votes^ metric. network. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Cardiovascular Drugs and Therapy Springer Journals

Loading next page...
 
/lp/springer_journal/primary-care-physician-perspectives-on-barriers-to-statin-treatment-aP8LRlYMkJ
Publisher
Springer US
Copyright
Copyright © 2017 by Springer Science+Business Media, LLC
Subject
Medicine & Public Health; Cardiology
ISSN
0920-3206
eISSN
1573-7241
D.O.I.
10.1007/s10557-017-6738-x
Publisher site
See Article on Publisher Site

Abstract

Cardiovasc Drugs Ther (2017) 31:303–309 DOI 10.1007/s10557-017-6738-x ORIGINAL ARTICLE Primary Care Physician Perspectives on Barriers to Statin Treatment 1 2 3 3 Rikki M. Tanner & Monika M. Safford & Keri L. Monda & Benjamin Taylor & 4 4 1 5 Ronan O’Beirne & Melanie Morris & Lisandro D. Colantonio & Ricardo Dent & 1 6 Paul Muntner & Robert S. Rosenson Published online: 14 July 2017 Springer Science+Business Media, LLC 2017 Abstract robin fashion. Then, each PCP independently ranked their Purpose Discontinuation of statin therapy represents a major top three responses to each question. For each PCP, the challenge for effective cardiovascular disease prevention. It is most important reason was given a weight of 3 votes, and unclear how often primary care physicians (PCPs) re-initiate the second and third most important reasons were given statins and what barriers they encounter. We aimed to identify weights of 2 and 1, respectively. We categorized the indi- PCP perspectives on factors influencing statin re-initiation. vidual responses into themes and determined the relative Methods We conducted six nominal group discussions with importance of each theme using a Bpercent of available 23 PCPs from the Deep South Continuing Medical Education votes^ metric. network.

Journal

Cardiovascular Drugs and TherapySpringer Journals

Published: Jul 14, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off